Savvy Updates, 9/16/24: Abbott Libre 3 Recall, FDA Clears Modular Medical PODD1 Pump, Air Flight Can Disrupt Pump Insulin Delivery, Roche to Launch Accu-Chek Smartguide CGM, Ozempic/Mounjaro & Metformin, Abvance Therapeutics Gets $3.9M for Novel Insulin & Glucagon Formulation, Dexcom CGM Worn in Space for 1st Time, Drug Interactions with GLP-1 Agonists & SGLT-2 Inhibitors, Semaglutide Impact on Body Composition, 4 largest PBMs Control 70% of Prescription Drug Market, Banana Leaves as New Source of Protein Powder

Savvy Updates, 9/16/24: Abbott Libre 3 Recall, FDA Clears Modular Medical PODD1 Pump, Air Flight Can Disrupt Pump Insulin Delivery, Roche to Launch Accu-Chek Smartguide CGM, Ozempic/Mounjaro & Metformin, Abvance Therapeutics Gets $3.9M for Novel Insulin & Glucagon Formulation, Dexcom CGM Worn in Space for 1st Time, Drug Interactions with GLP-1 Agonists & SGLT-2 Inhibitors, Semaglutide Impact on Body Composition, 4 largest PBMs Control 70% of Prescription Drug Market, Banana Leaves as New Source of Protein Powder

Sep 14, 2024 | Diabetes Business, Featured, Foods, Research News, Technology Updates

Continuous Glucose Monitoring (CGM) Sensor Recall: Abbott Diabetes Care Inc Issues Recall for Certain FreeStyle Libre 3 Sensors due to Risk for Inaccurate High Glucose Readings posted by FDA.gov/medical-devices, 5 September 2024. This recall involves removing...
Savvy Updates 7/29/24: Abbott FS Libre 3 Sensors Warning, Dexcom Stock Plummets, T1Ds Fear GLP-1s Will Edge Out Insulin, Sleep Apnea & Retinopathy, Diamyd Fast-Tracked, Shuren Leaves FDA CDRH, T1D Moonshot Robert Oringer, Embecta Considers Sale, SmartStart’s Interactive Educational Platform

Savvy Updates 7/29/24: Abbott FS Libre 3 Sensors Warning, Dexcom Stock Plummets, T1Ds Fear GLP-1s Will Edge Out Insulin, Sleep Apnea & Retinopathy, Diamyd Fast-Tracked, Shuren Leaves FDA CDRH, T1D Moonshot Robert Oringer, Embecta Considers Sale, SmartStart’s Interactive Educational Platform

Jul 29, 2024 | Advocacy, Diabetes Business, Featured, Research News, Technology Updates, Videos

Abbott Issues Warning for Certain FreeStyle Libre 3 Sensors by Paul Heltzel for diaTribe.org, 25 July 2024. Some FreeStyle Libre 3 continuous glucose monitoring sensors could display false high readings and should be immediately discontinued, urged the manufacturer....
Savvy Updates 6/17/24: Abbott Lingo & Libre Rio, Oral Insulin, Sensulin Smart Insulin, Biomea Fusion on Clinical Hold, Hydration Hacks, CGM Insurance Coverage, Diabetes Products Putting Profits Over Patients

Savvy Updates 6/17/24: Abbott Lingo & Libre Rio, Oral Insulin, Sensulin Smart Insulin, Biomea Fusion on Clinical Hold, Hydration Hacks, CGM Insurance Coverage, Diabetes Products Putting Profits Over Patients

Jun 17, 2024 | Diabetes Business, Featured, Podcasts, Research News, Technology Updates

FDA approves Abbott’s Lingo and Libre Rio glucose monitoring systems by Archana Rani for MedicalDevice-Network.com, June 2024. The US Food and Drug Administration (FDA) has approved Abbott’s Lingo and Libre Rio over-the-counter continuous glucose monitoring (CGM)...
Skip to content